Who is sponsoring NCT04779333?

NCT04779333 is sponsored by Seattle Children's Hospital.

What drugs are being tested in NCT04779333?

Interventions in NCT04779333: LEAP, Standard BMT.

What condition does NCT04779333 study?

NCT04779333 studies Attention Deficit Hyperactivity Disorder.

Is NCT04779333 still recruiting?

NCT04779333 is currently completed. Last updated 6 May 2023.

Last reviewed 2023-05-06 · How we verify

NCT04779333: LEAP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Lifestyle Enhancement for ADHD Program 2

Completed NA Last updated 6 May 2023

What this trial tests

NA trial testing LEAP in Attention Deficit Hyperactivity Disorder in 88 participants. Completed in 28 April 2023.

Timeline

9 September 2020

Primary endpoint
28 April 2023

28 April 2023

Quick facts

Lead sponsor	Seattle Children's Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	88
Start date	9 September 2020
Primary completion	28 April 2023
Estimated completion	28 April 2023
Sites	1 location across United States

Drugs / interventions tested

LEAP
Standard BMT

Conditions studied

Attention Deficit Hyperactivity Disorder — all drugs for Attention Deficit Hyperactivity Disorder →

Sponsor

Seattle Children's Hospital

Who can join

Adults 6 to 10, any sex, with Attention Deficit Hyperactivity Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to increase physical activity (PA) in children with ADHD using a novel, family-based intervention that promotes PA within the context of evidence-based behavioral management training (BMT) for caregivers, enhanced with mobile health (mHealth) behavior change strategies. Primary Objective: To evaluate the primary effects of a 9-week, family-based intervention (Lifestyle Enhancement for ADHD Program - LEAP) to promote PA in young children with ADHD Secondary: To evaluate secondary effects of the LEAP program on child ADHD symptoms and executive functioning

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Modernizing behavioral parent training program for ADHD with mHealth strategies, telehealth groups, and health behavior curriculum: a randomized pilot trial.
Tandon PS, Gabert T, Kuhn M, Tran N, et al · · 2024 · PMID 39279226 · DOI 10.1093/jpepsy/jsae073

Verify or expand the search:

Other trials of LEAP

Trials testing the same drug.

NCT06011759 — Maintaining Implementation Through Dynamic Adaptations (MIDAS) Suicide Prevention 2.0 Clinical Telehealth · NA · completed
NCT05065502 — MIDAS Cluster Randomized Controlled Trial of Implementation Strategies to Optimize Use of Medications in VA Clinical Set · NA · completed
NCT04302740 — Life Enhancing Alcohol-management Program · NA · completed
NCT02765412 — PrOVE QUERI Project #1 · completed
NCT02825680 — Learn, Engage, Act, Process (LEAP) for MOVE! · NA · completed

Other recruiting trials for Attention Deficit Hyperactivity Disorder

Currently open trials in the same condition.

NCT07001475 — A Study to Test How BI 3031185 is Tolerated by People With Borderline Personality Disorder or Attention-deficit/Hyperact · Phase 1 · recruiting
NCT06847165 — Trigeminal Nerve Stimulation for Children With Prenatal Alcohol Exposure · NA · recruiting
NCT06325813 — ADHD PreSMA Response Inhibition Therapy · NA · recruiting
NCT06248229 — A Trial of Dyanavel XR in Treating Co-occurring Fatigue Symptoms in Adults With Attention Deficit Hyperactivity Disorder · Phase 4 · recruiting
NCT06232226 — Attention Deficit Hyperactivity Disorder · NA · recruiting

Other Seattle Children's Hospital trials

Trials by the same sponsor.

NCT07522112 — Evaluating a Shared Decision-making Intervention for Families About Firearm Storage · NA · not yet recruiting
NCT06864611 — Evaluating Huddles as a Novel Approach to Improving Concussion Safety · NA · not yet recruiting
NCT07424157 — Long-Term Follow-Up of Subjects Treated With Seattle Children's Therapeutics Gene Therapy Products · not yet recruiting
NCT07148050 — Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimer · Phase 1 · recruiting
NCT07097792 — Concussion Recovery and Support Program · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04779333 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Seattle Children's Hospital
Last refreshed: 6 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04779333.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing